TDG Form 4: Officer Exercises 3,000 Options and Sells 3,000 Shares
Joel Reiss, Co-Chief Operating Officer of TransDigm Group (TDG), reported insider transactions on 08/20/2025.
Rhea-AI Filing Summary
Joel Reiss, Co-Chief Operating Officer of TransDigm Group (TDG), reported insider transactions on 08/20/2025. He exercised stock options to acquire 3,000 shares at an exercise price of $284.97, then sold a total of 3,000 common shares in multiple blocks at weighted average prices in the approximate ranges of $1,399.40–$1,413.60. After these transactions the reporting person beneficially owned 3,600 common shares directly. The filing also shows beneficial ownership of 53,000 shares underlying stock options exercisable through 11/08/2027. The report indicates the transactions were made pursuant to a written plan consistent with Rule 10b5-1.
Positive
- Transactions reported under a 10b5-1 plan, indicating pre-arranged trading consistent with compliance practices
- Retains significant derivative-based ownership (53,000 shares underlying exercisable options through 11/08/2027), maintaining long-term exposure
Negative
- Sold 3,000 common shares in multiple blocks at weighted average prices roughly between $1,399.40 and $1,413.60, reducing direct holdings
- Direct common shares declined to 3,600 after the reported transactions
Insights
TL;DR: Insider exercised options and sold an equal number of shares under a 10b5-1 plan; substantive derivative holdings remain large.
The filing documents a routine option exercise (3,000 shares at $284.97) followed by sales of 3,000 shares executed in multiple blocks at weighted average prices roughly between $1,399 and $1,413. The reporting person retains sizable option-based exposure (53,000 underlying shares exercisable through 11/08/2027) and holds 3,600 shares directly after the trades. The checkbox indicating the transaction was made pursuant to a written plan signals pre-arranged trading consistent with Rule 10b5-1, which reduces informational-timing concerns about the sales.
TL;DR: Transactions appear structured and compliant; material governance implications are limited based on disclosed facts.
The filer identified as an officer and checked the box indicating the use of a written trading plan, suggesting adherence to an affirmative defense under Rule 10b5-1. The one-day sequence—option exercise paired with contemporaneous share dispositions—matches common insider liquidity transactions. Disclosed exercisable options (53,000 shares) maintain the officer's long-term economic alignment with shareholders.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 3,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 3,000 | $284.97 | $855K |
| Sale | Common Stock | 487 | $1,399.60 | $682K |
| Sale | Common Stock | 287 | $1,401.01 | $402K |
| Sale | Common Stock | 342 | $1,403.59 | $480K |
| Sale | Common Stock | 343 | $1,404.50 | $482K |
| Sale | Common Stock | 158 | $1,405.68 | $222K |
| Sale | Common Stock | 152 | $1,406.58 | $214K |
| Sale | Common Stock | 22 | $1,407.09 | $31K |
| Sale | Common Stock | 200 | $1,408.62 | $282K |
| Sale | Common Stock | 238 | $1,410.29 | $336K |
| Sale | Common Stock | 571 | $1,411.41 | $806K |
| Sale | Common Stock | 200 | $1,413.00 | $283K |
Footnotes (8)
- F1. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1399.40 - $1400.01. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1400.57 - $1401.43. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1402.98 - $1403.88. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1404.00 - $1404.97. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1405.01 - $1406.00. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1406.08 - $1407.00. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F7. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1410.21 - $1410.31. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F8. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $1411.27 - $1411.60. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When did Joel Reiss file the Form 4 disclosing TDG transactions?
What were Joel Reiss's holdings after the transactions?
Were the transactions executed under a trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.